Overview of Discovery & Development Informatics at Lilly Rick Bishop, Manager, DDIT Phil Brooks,...
-
Upload
howard-weaver -
Category
Documents
-
view
222 -
download
2
Transcript of Overview of Discovery & Development Informatics at Lilly Rick Bishop, Manager, DDIT Phil Brooks,...
Overview of Discovery & Development Informatics at Lilly
Rick Bishop, Manager, DDITPhil Brooks, Information Consultant, DDITHans Constandt, Senior Business Consultant, DDITAndy Ring, Information Consultant, DDIT Susie Stephens, Manager, DDIT
Agenda
• Introduction to Lilly
• Discovery & Development Informatics Plans
• External Focus
Introduction to Lilly
Eli Lilly Background
• A heritage more than 130 years strong
• Headquarters located in Indianapolis, Indiana, USA
• Approximately 40,000 employees worldwide
• Approximately 8,000 employees engaged in R&D
• Clinical research conducted in more than 50 countries
• Research and development facilities located in 8 countries
• Manufacturing plants located in 13 countries
• Products marketed in 143 countries
Breakthrough Products
** Lilly has launched 9 new products since 2001
** Malignant pleural mesothelioma and lung cancer
** Type II diabetes (developed and marketed in partnership with Amylin pharmaceuticals)
** Erectile dysfunction
** Major depression and DPNP (Partnership with Quintiles)
Osteoporosis in women past menopause
** Osteoporosis for men and women in post menopause who are susceptible to fractures
Cancer (pancreatic and non-small-cell lung cancer; bladder and breast cancer in Europe)
Type 1 & Type 2 Diabetes
Humatrope Growth deficiency
Type 1 & Type 2 Diabetes
Cardiac ischemic complications (developed by Centocor, marketed by Lilly)
** Treatment of ADHD
** Treatment of bipolar depression
** Treatment of severe sepsis
** Stress urinary incontinence (marketed in Europe with Boehringer Ingelheim)
Schizophrenia, bipolar mania, and bipolar maintenance
Discovery & Development Informatics
• Functional Areas• Biology• Chemisty• ADME/Tox• Experimental Medicine• Process R&D
• Skills• Informatics• Software engineering• Systems integration• Discovery PMO• Discovery COE• External Surveillance
• MaryJo Zaborowski, Information Officer• 230 employees globally
Industry spends more to get less
Source: PhRMA, FDA, Lehman Bros.
Patient-centric Focus
Silos Need to be Broken Down
Data
Transform
Model &Understand
Generate/TestHypothesis
Analyze& Mine
Target Hit Lead PgS CS FHD FED PD/RD FS FA FL GL
TargetToHit
HitTo
Lead
LeadTo
PgS
LeadOptimization
Pre-ClinicalDevelopment
Phase I Phase 2 Phase 3Registration
LaunchGlobalLaunch
Project Program Product
Exploratory
Data
Transform
Model &Understand
Generate/TestHypothesis
Analyze& Mine
Data
Transform
Model &Understand
Generate/TestHypothesis
Analyze& Mine
Data
Transform
Model &Understand
Generate/TestHypothesis
Analyze& Mine
Data
Transform
Model &Understand
Generate/TestHypothesis
Analyze& Mine
Data
Transform
Model &Understand
Generate/TestHypothesis
Analyze& Mine
Data
Transform
Model &Understand
Generate/TestHypothesis
Analyze& Mine
Data
Transform
Model &Understand
Generate/TestHypothesis
Analyze& Mine
Data
Transform
Model &Understand
Generate/TestHypothesis
Analyze& Mine
Data
Transform
Model &Understand
Generate/TestHypothesis
Analyze& Mine
Integrating Heterogeneous Data
Cell/AssayTechnologies
Re-Aligning IT Spend
Source: Professor Peter Weill, MIT Sloan School of Management
Discovery & Development Informatics Plans
CustomSoftwareEngineering
SystemsIntegration
ResearchOperations
Workflow/BusinessLogic
Discovery SOA Components
OntologyData Consumers
Data Providers
Integration Services
Custom
COTS
Composite Application
Application
CRO
OpsDB
Mart
WS
WS WS
WS WSWS
WS
Application
OpsDB
Application
OpsDB
Application
OpsDB
Semantic Layer
Discovery Metadata: Architecture
Application 1 Application 2 Application 3 …
SOA Layer/Enterprise Service Bus
(WebServices, Visualizers, DataAccess Components)Authentication
SOA
DATA
APPS
SQL SPARQL
SourceModel 1
SourceModel 2
SourceModel 3
SourceModel 4
LocalAssertions
Top LevelOntology
Provenance
OtherSources
OtherSources
Source…
ETL
OtherTools
SpreadsheetsRdbms
Proposed Architecture
RDF XMLRDF CSV Web RDBMS
Top levelontology
RDF RDF RDBMSRDF RDBMS RDBMS
Sparql endpoints
Manual
Autom
ated
Semantic pipes
RDF
Middleware - Relational2RDF
XLS
RDBMS
Docs RDBMS
(**) – URI / Unique resource identifiers
Lilly &PublicStructured & UnstructuredData sources.
Standardize (*) – (**)
Client APIsC#, Java, Ruby
Browsers & VisualizationDatamarts
/Warehouses
Desktop applications
DomainOntologies& vocabs
DomainOntologies& vocabs
DomainOntologies& vocabs
(*) – Data clean, map to vocabularies, ontologies
Security – http standard
Lilly Securitystandards:
LillyNetDIT, GMR
LSG Going Forward
• Evolve CAB toward CompositeWCF
• Establish ESB• D2R
• Establish SOA fabric• Governance - Design time • Monitoring - Run time
• Extend semantics within LSG messaging
• Incorporate semantic provenance
External Focus
Open Innovation Group Activities
• Identify suitable innovation projects from the DDIT portfolio
• Work with internal scientist &/or external collaborators to create POCs of the identified projects
• Demonstrate value of innovation projects within DDIT
• Showcase novel solutions to senior management in LRL
• Promote work of group through Web site, newsletter, etc.
• Scout for interesting new technologies from universities, standards organizations
• Write up brief reviews of interesting technologies for dissemination across DDIT
• Organize presentations/demos of appealing technologies to DDIT
• Support Lilly’s open source projects
• Influence development of 3rd party products to better meet our needs
Benefits of Open Innovation Team
• Fast assessment of the value of a technology
• Quick delivery of informatics solutions to LRL that meet prioritized scientific needs
• Increased awareness of how emerging technologies may change the landscape in 3-5 yrs
• Streamlined dissemination of information about new technologies
• Use knowledge gained to make best investments going forwards
• Establish relationships with key technology players for the future environment
• Influence vendors to develop solutions in ways that work for us
• Increased success in using tools from academia
• More formalized process for developing ‘supported’ technologies
• Ability to more easily utilize output from the Open Innovation Center
• Raise awareness of DDIT and the importance of IT within LRL
Ongoing Open Innovation Projects
• RDF Access to Relational Databases• Eric Prud'hommeaux
• End User Semantic Web Authoring• David Karger
• Scientist-Driven Semantic Integration of Knowledge in AD• Tim Clark, June Kinoshita
• Provenance Collection and Management• Carole Goble, Beth Plale
• Linking Open Drug Data• Chris Bizer
• Drug Target Networks• Lászó Barabási
Standards Group Participation
• W3C– HCLS IG, RDB2RDF XG, Social Networking Workshop, tracking
WACG, likely participation in DAWG• CDISC
– SDTM, Metadata Repository, SEND• HL7• The Open Group• EBI’s Industry Consortium
Conclusions
• Lilly is a successful mid-sized pharma company
• The pharma industry is under considerable pressure to become more effective
• Industry shifts requires a greater exploitation of information
• Need greater adoption of innovative solutions in cutting edge infrastructure and informatics
• LSG, Semantic Web and SOA are all in our architectural plans
• Increased focus on external collaborations